Odyssey Therapeutics stock

Odyssey Therapeutics Stock

HealthTech
Looking to sell Odyssey Therapeutics Stock or Options? Get a free valuation
Founded: 2021Funding to Date: $492M
Visit website

Odyssey Therapeutics is a biotechnology company that focuses on the development of immunomodulators and oncology drugs. The main goal of the company is to revolutionize the drug discovery field with its innovative product pipeline, while also speeding up the clinical development process. This allows the healthcare industry to have access to the next generation of precision immunomodulators and oncology medicines.

Investors Include:

Ascenta Capital, Foresite Capital, Logos Capital, General Catalyst, BlackMars Capital, GreatPoint Ventures, AB Magnitude Ventures Group, The Healthcare Innovation Investment Fund LLC, Alexandria Venture Investments, HBM Healthcare Investments, KB Investment, Global BioAccess Fund, Woodline Partners, Creacion Ventures, Catalio Capital Management, HBM Partners, OrbiMed, T. Rowe Price Group, Walleye Capital, Balderton Capital, Sanofi Ventures, SR One Capital Management, Colt Ventures, Fidelity Management & Research.

Own Odyssey Therapeutics stock or options?

Get an instant valuation

  • Completely free
  • 100% confidential & secure
  • Takes less than a minute
100% private & secure